MetLife, Inc.
MET
$77.36
$0.801.05%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 71.03B | 71.23B | 70.05B | 69.49B | 69.74B |
| Total Other Revenue | 1.98B | 2.27B | 936.00M | 1.86B | -971.00M |
| Total Revenue | 73.01B | 73.49B | 70.98B | 71.34B | 68.77B |
| Cost of Revenue | 54.23B | 54.53B | 53.46B | 53.10B | 53.38B |
| Gross Profit | 18.78B | 18.96B | 17.53B | 18.24B | 15.39B |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 12.25B | 12.12B | 11.98B | 11.93B | 11.86B |
| Total Operating Expenses | 66.48B | 66.65B | 65.44B | 65.03B | 65.24B |
| Operating Income | 6.54B | 6.84B | 5.55B | 6.31B | 3.53B |
| Income Before Tax | 5.71B | 5.93B | 5.62B | 5.18B | 3.72B |
| Income Tax Expenses | 1.41B | 1.41B | 1.18B | 1.40B | 785.00M |
| Earnings from Continuing Operations | 4.30K | 4.52K | 4.44K | 3.78K | 2.94K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -14.00M | -15.00M | -18.00M | -21.00M | -28.00M |
| Net Income | 4.29B | 4.50B | 4.43B | 3.76B | 2.91B |
| EBIT | 6.54B | 6.84B | 5.55B | 6.31B | 3.53B |
| EBITDA | 7.25B | 7.56B | 6.26B | 7.04B | 4.25B |
| EPS Basic | 5.94 | 6.18 | 6.00 | 4.99 | 3.73 |
| Normalized Basic EPS | 5.16 | 5.30 | 4.96 | 4.51 | 3.16 |
| EPS Diluted | 5.90 | 6.15 | 5.97 | 4.96 | 3.71 |
| Normalized Diluted EPS | 5.13 | 5.27 | 4.93 | 4.48 | 3.14 |
| Average Basic Shares Outstanding | 2.75B | 2.79B | 2.83B | 2.87B | 2.92B |
| Average Diluted Shares Outstanding | 2.76B | 2.80B | 2.84B | 2.89B | 2.94B |
| Dividend Per Share | 2.20 | 2.18 | 2.16 | 2.13 | 2.11 |
| Payout Ratio | 39.96% | 38.25% | 39.02% | 46.15% | 59.99% |